皮肤疾病管理项目

Search documents
阿里健康与利奥制药达成战略合作,共探数字化健康管理新模式
Zheng Quan Shi Bao Wang· 2025-09-01 03:40
Core Insights - Alibaba Health and LEO Pharma have announced a strategic partnership focused on digital health management and innovative drug accessibility, aiming to enhance patient care and streamline health services [1] - The collaboration marks a significant milestone in the integration of internet platforms with the pharmaceutical industry, emphasizing patient-centered digital health management [1] - Both companies aim to leverage their strengths to improve the management of chronic skin diseases, providing personalized and efficient health management solutions [1] Company Collaboration - The partnership will explore scientific management of post-diagnosis home care scenarios, enhancing the treatment adherence and accessibility of innovative medications [1] - Alibaba Health's CEO highlighted the integration of LEO's innovative drugs with their digital capabilities to facilitate easier treatment adherence for patients [1] - LEO Pharma's executive emphasized the transformative impact of digital technology on healthcare, aiming to provide comprehensive support for patients with skin diseases [1] Project Outcomes - Previous collaborations have yielded significant results, with a notable 30% increase in medication adherence among patients involved in the skin disease management project [2] - Patients participating in chronic disease community management experienced a 3.2 times increase in medication adherence, leading to improved disease control [2] - These outcomes demonstrate the effectiveness of digital interventions in managing chronic skin diseases and provide valuable insights for the industry [2]
阿里健康与利奥制药达成战略合作
Zhong Guo Jin Rong Xin Xi Wang· 2025-08-29 10:15
Core Viewpoint - Alibaba Health and LEO Pharma have announced a strategic partnership to enhance digital health management and improve accessibility to innovative medications for patients [1][2]. Group 1: Strategic Collaboration - The collaboration will focus on new technology-driven medical innovations, comprehensive health management, and improving the accessibility of innovative drugs [1]. - Alibaba Health has established partnerships with thousands of pharmaceutical companies globally, leveraging its digital capabilities and online channel advantages [1]. - LEO Pharma has been dedicated to promoting scientific understanding and standardized treatment awareness for skin diseases in China, helping over 65 million patients through various initiatives [1]. Group 2: Project Outcomes - Previous collaborations have led to significant results in skin disease management projects, enhancing patient adherence to medication and self-management of diseases [1]. - Data indicates that patient adherence to medication improved by 30% compared to the previous year, with a 3.2 times increase in adherence among patients participating in chronic disease community management [1]. Group 3: Future Directions - The partnership aims to further explore scientific management in post-diagnosis home settings, providing more intelligent, personalized, and efficient health management solutions for patients [2].